Velo3D, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Velo3D, Inc. on May 15, 2026. The filing discloses the entry into a new material definitive agreement to facilitate an "at-the-market" equity offering and the simultaneous termination of a prior sales agreement.
Key Financial Metrics and Transaction Details
- Offering Size: Up to $100,000,000 in aggregate offering price of common stock.
- Commission: Sales Agents will receive a commission of 3.0% of aggregate gross proceeds.
- Use of Proceeds: Intended for working capital and general corporate purposes.
- Financial Performance: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- New Agreement: Entered into a Sales Agreement with Needham & Company, LLC, Cantor Fitzgerald & Co., and Craig-Hallum Capital Group, LLC to sell shares via an effective shelf registration statement (Form S-3 No. 333-294876).
- Termination: Terminated the prior sales agreement dated February 6, 2023, with Needham & Company, LLC. No termination penalties were incurred.
Outlook, Risks, and Management Commentary
- Sales Obligation: The Company is not obligated to sell any shares under the new agreement.
- Uncertainty: No assurance is given regarding the price, amount, or timing of any potential share sales.
- Termination: The offering will terminate upon the sale of all shares subject to the agreement or earlier termination of the Sales Agreement.
- Legal Disclaimer: The filing explicitly states it is not an offer to sell securities and that the Sales Agreement is not intended as a document for investors to obtain factual information about the Company's current state of affairs.
Investor Verification Checklist
- Verify the current share price and market capitalization to assess the potential dilution impact of a $100 million offering.
- Review the Company's most recent 10-K or 10-Q filings for actual liquidity, cash position, and working capital needs.
- Confirm the status of the shelf registration statement (No. 333-294876) and any subsequent prospectus supplements.
- Monitor future 8-K filings for actual sales activity, pricing, and total proceeds raised under this new agreement.